Follicular Lymphoma News and Research

RSS
Cancer patients share survivorship story, celebrate strength and self-care

Cancer patients share survivorship story, celebrate strength and self-care

HCA Healthcare UK introduces ground-breaking new blood cancer treatment

HCA Healthcare UK introduces ground-breaking new blood cancer treatment

T-cells play key role in how the body fights follicular lymphoma

T-cells play key role in how the body fights follicular lymphoma

CAR T therapy can lead to long-lasting remissions in patients with r/r diffuse large B-cell lymphoma

CAR T therapy can lead to long-lasting remissions in patients with r/r diffuse large B-cell lymphoma

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase 2 results on tazemetostat EZH2 inhibitor to be presented at ESMO 2018

Phase 2 results on tazemetostat EZH2 inhibitor to be presented at ESMO 2018

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Verastem Oncology selects US Bioservices to dispense COPIKTRA capsules

Verastem Oncology selects US Bioservices to dispense COPIKTRA capsules

FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials

FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Verastem doses first patient in Phase I/II clinical trial of duvelisib in combination with venetoclax

Celgene to share new and updated data around novel hematological therapies

Celgene to share new and updated data around novel hematological therapies

New compounds targeting epigenetics show promise in lymphoma patients

New compounds targeting epigenetics show promise in lymphoma patients

Study reveals HCT as effective treatment for NHL patients regardless of age

Study reveals HCT as effective treatment for NHL patients regardless of age

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients

VICC selected to administer FDA-approved CAR T therapy for treatment of lymphoma patients

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

Dana-Farber, Brigham and Women's Cancer Center certified to offer new CAR T-cell therapy

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

FDA grants accelerated approval to new drug for treating relapsed follicular lymphoma

Investigational compound for treating indolent lymphomas shows positive results in phase II clinical study

Investigational compound for treating indolent lymphomas shows positive results in phase II clinical study

Study shows promising results for treating lymphoma patients with immune cell therapy

Study shows promising results for treating lymphoma patients with immune cell therapy

New study reveals CAR T cells can function as micro-pharmacies for precise therapeutic delivery

New study reveals CAR T cells can function as micro-pharmacies for precise therapeutic delivery